- Home
- ZKIN vs PHIO Comparison
ZKIN vs PHIO Comparison
Compare ZKIN & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZKIN
- PHIO
- Stock Information
- Founded
- ZKIN 2015
- PHIO 2011
- Country
- ZKIN China
- PHIO United States
- Employees
- ZKIN N/A
- PHIO N/A
- Industry
- ZKIN Metal Fabrications
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- ZKIN Industrials
- PHIO Health Care
- Exchange
- ZKIN Nasdaq
- PHIO Nasdaq
- Market Cap
- ZKIN 10.3M
- PHIO 11.9M
- IPO Year
- ZKIN 2017
- PHIO N/A
- Fundamental
- Price
- ZKIN $2.54
- PHIO $2.54
- Analyst Decision
- ZKIN
- PHIO Strong Buy
- Analyst Count
- ZKIN 0
- PHIO 2
- Target Price
- ZKIN N/A
- PHIO $9.00
- AVG Volume (30 Days)
- ZKIN 182.5K
- PHIO 166.6K
- Earning Date
- ZKIN 01-27-2025
- PHIO 08-13-2025
- Dividend Yield
- ZKIN N/A
- PHIO N/A
- EPS Growth
- ZKIN N/A
- PHIO N/A
- EPS
- ZKIN N/A
- PHIO N/A
- Revenue
- ZKIN $108,199,877.00
- PHIO N/A
- Revenue This Year
- ZKIN N/A
- PHIO N/A
- Revenue Next Year
- ZKIN N/A
- PHIO N/A
- P/E Ratio
- ZKIN N/A
- PHIO N/A
- Revenue Growth
- ZKIN N/A
- PHIO N/A
- 52 Week Low
- ZKIN $0.82
- PHIO $0.97
- 52 Week High
- ZKIN $6.30
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- ZKIN 55.69
- PHIO 58.22
- Support Level
- ZKIN $2.31
- PHIO $2.31
- Resistance Level
- ZKIN $3.41
- PHIO $2.45
- Average True Range (ATR)
- ZKIN 0.34
- PHIO 0.14
- MACD
- ZKIN 0.05
- PHIO 0.00
- Stochastic Oscillator
- ZKIN 43.87
- PHIO 74.19
About ZKIN ZK International Group Co. Ltd
ZK International Group Co Ltd is engaged in the manufacture and marketing of metal pipes. The company is specialized in producing double-press thin-walled stainless steel tubes and fittings, carbon steel tubes and fittings, single-press tubes and fittings, and stainless-steel strips. The products are used in restaurants, hotels, hospitals, firefighting, food, beverage, ships, engines, industrial seawater desalination and systems of direct-drinking water, cold /hot water supply, city water supply, and gas of large/middle scale construction projects.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.